Food and Drug Administration, et al., Petitioners v. R.J. Reynolds Vapor Co., et al.

The Supreme Court ruled 7-2 that retailers have the legal right to challenge the FDA's denial of tobacco marketing applications. The Court found that the Tobacco Control Act's phrase 'any person adversely affected' includes the stores that sell the products, not just the companies that make them. This means retailers can join or lead lawsuits when the government blocks a product they intended to sell.

This decision makes it easier for small businesses and retailers to fight federal regulations in court. For example, a local vape shop can now sue to keep a specific e-cigarette on its shelves even if the manufacturer is not the one filing the lawsuit. It limits the FDA's ability to restrict products without facing legal challenges from every level of the supply chain.

The case centers on 'standing,' which is the legal right to bring a case to court. Historically, the Court has debated how closely a person must be related to a government action to sue over it. By interpreting 'adversely affected' broadly, the Court is allowing more parties to challenge the 'administrative state' (the collection of federal agencies that create rules).

Justice Amy Coney Barrett wrote the majority opinion for a 7-2 Court, joined by Chief Justice Roberts and Justices Thomas, Alito, Kagan, Gorsuch, and Kavanaugh. Justice Ketanji Brown Jackson wrote a dissent joined by Justice Sotomayor.

“The phrase 'adversely affected' is a term of art in administrative law that the Court has consistently interpreted broadly to cover anyone arguably within the zone of interests to be protected or regulated.”

“Retailers fall outside the statute’s zone of interests because the premarket approval scheme involves only manufacturers and the FDA, with no mechanism for retailer participation.”

Retailers who lose profits or face penalties due to FDA product denials have the legal standing to sue the agency.

The case will return to lower courts to address the specific marketing denials for R.J. Reynolds' flavored vape products. Other industries may use this ruling to argue that their own retailers should be allowed to sue different federal agencies. The FDA will likely face a new wave of lawsuits from sellers every time it denies a new product application.

The FDA argued only manufacturers could challenge marketing denials. R.J. Reynolds argued that retailers are also harmed by these decisions and should have a voice in court.

Retailers can now protect their profits by suing to keep products available. They no longer have to rely solely on manufacturers to fight the FDA in court.

The Court applied the 'zone of interests' test. This rule allows anyone 'arguably' affected by a law to seek judicial review (a court's power to check agency actions).

The case is remanded (sent back) to the lower courts. Those courts must now decide if the FDA's original denial of the vape products was actually legal.

The ruling follows a trend of the Court making it easier for private parties to challenge federal agencies. It limits the government's power to define who can sue them.